Publications
- Highly active RRMS and ocrelizumab after failure of alemtuzumab therapy2020 | Faculty of Medicine in Hradec Králové
- Induction therapy and multiple sclerosis2019 | Faculty of Medicine in Hradec Králové
- CD4+/CD45RO+: A Potential Biomarker of the Clinical Response to Glatiramer Acetate2019 | Faculty of Medicine in Hradec Králové
- Monitoring of Lymphocyte Populations During Treatment with Interferon--1b to Predict Multiple Sclerosis Disability Progression2019 | Faculty of Medicine in Hradec Králové
- Ocrelizumab, clinical activity and progression - long - term data2019 | Faculty of Medicine in Hradec Králové
- Pharmacovigilance of novel treatments for multiple sclerosis2019 | Faculty of Medicine in Hradec Králové
- Evalution of multiple sclerosis activity and disability2019 | Faculty of Medicine in Hradec Králové
- Current treatment strategies for multiple sclerosis2019 | Faculty of Medicine in Hradec Králové
- Tolerability, treatment satisfaction and quality of life outcomes in stable multiple sclerosis patients switched from injectable therapies to auto injected intramuscular interferon beta 1a: The SFERA study2019 | Faculty of Medicine in Hradec Králové
- Treatment of behavioral and psychological symptoms of dementias with psychopharmaceuticals: a review2018 | Faculty of Medicine in Hradec Králové
Loading network view...